No Infections Seen After Transperineal Biopsy for Prostate Cancer
MONDAY, Sept. 30, 2024 -- For patients with suspicion for prostate cancer, transperineal biopsy has similar cancer detection rates as transrectal biopsy but a significantly lower risk for infection, according to a research letter published online Sept. 19 in JAMA Oncology.
Jim C. Hu, M.D., M.P.H., from the New York Presbyterian Weill Cornell Medicine Hospital in New York City, and colleagues randomly assigned patients with suspicion for prostate cancer to clinic-based transperineal biopsy (without antibiotic prophylaxis) or transrectal biopsy (with targeted prophylaxis). A total of 875 patients were randomly assigned from February 2021 through March 2024; 372 and 370 underwent biopsy in the transperineal and transrectal groups, respectively.
The researchers found no infections in the transperineal group versus six infections in the transrectal group in an intent-to-treat analysis (difference, −1.6 percent). Low and similar rates of other complications were seen. Overall, 55 and 52 percent of patients in the transperineal and transrectal groups, respectively, had high-grade cancer (difference, 2.9 percent).
"Transperineal biopsy significantly lowers the risk of infectious complications versus transrectal biopsy," the authors write. "Transperineal biopsy should be the standard of care for prostate biopsy."
One author disclosed financial ties to Perineologic and KOELIS.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Smoking Tied to Increased Risk for Type 2 Diabetes
WEDNESDAY, Sept. 17, 2025 -- Smoking increases the risk for type 2 diabetes across all disease subtypes, according to a study presented at the annual meeting of the European...
Weight-Loss Surgery Bests Medical Weight Management for Obesity-Related Risk Mitigation
WEDNESDAY, Sept. 17, 2025 -- Bariatric surgery is associated with a significantly lower risk for developing major metabolic comorbidities compared with a medical weight management...
Parent-Focused Interventions Do Not Prevent Obesity at Age 24 Months
TUESDAY, Sept. 16, 2025 -- Parent-focused behavioral interventions seem to be insufficient for preventing obesity at age 24 months, according to a review published online Sept. 10...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.